Tivic Health Systems Inc. (NASDAQ:TIVC ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Jennifer Ernst – Chief Executive Officer Lisa Wolf – Interim Chief Financial Officer Michael Handley – Chief Operating Officer and President-Tivic Biopharma Division Conference Call Participants Operator Welcome to Tivic Health Systems First Quarter 2025 Financial Results and Operational Update Conference Call. This call has been prerecorded, and the questions you have submitted in advance will be answered following the prepared remarks.
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today it is expanding its non-invasive VNS patent portfolio with the filing of a new patent application with the United States Patent and Trademark Office. Patent No. 63,801,058 entitled “Vagus Nerve Stimulation System” expands the claims and protection around the technology that Tivic is developing and which it expects will redefine state-of-the art in non-invasive vagus.
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced that, on March 28, 2025, it exercised its licensing option for the exclusive, worldwide rights to advance Entolimod™ for a second indication, Neutropenia. This expansion of commercial rights is part of the license agreement with Statera Biopharma for its late-stage Toll-like Receptor 5 (TLR5) immunotherapy program Entolimod™. Neutropenia is a condition characterized b.
16 May 2025 Date | | - Cons. EPS | - EPS |
21 Mar 2025 Date | | - Cons. EPS | - EPS |
15 Nov 2024 Date | | - Cons. EPS | - EPS |
15 Aug 2024 Date | | - Cons. EPS | - EPS |
16 May 2024 Date | | - Cons. EPS | - EPS |
16 May 2025 Date | | - Cons. EPS | - EPS |
21 Mar 2025 Date | | - Cons. EPS | - EPS |
15 Nov 2024 Date | | - Cons. EPS | - EPS |
15 Aug 2024 Date | | - Cons. EPS | - EPS |
16 May 2024 Date | | - Cons. EPS | - EPS |
Medical - Devices Industry | Healthcare Sector | Ms. Jennifer Ernst CEO | NASDAQ (CM) Exchange | 888705100 Cusip |
US Country | 7 Employees | - Last Dividend | 7 Mar 2025 Last Split | 11 Nov 2021 IPO Date |
Tivic Health Systems Inc. is a pioneering health technology company that is dedicated to the development and commercialization of non-invasive bioelectronic medicine. Founded in 2016 and based in Hayward, California, Tivic Health Systems Inc. is at the forefront of innovative treatments focusing on the well-being of its customers. The company leverages advanced technology to provide solutions that address common health concerns in a novel, safe, and effective manner. Its operations span direct-to-consumer sales through its own website and well-known online marketplaces, ensuring accessibility and convenience for consumers across the United States.
ClearUP is Tivic Health Systems Inc.'s flagship product, which epitomizes the company's commitment to bioelectronic medicine. This innovative device is specifically designed for the treatment of sinus and nasal congestion pain. It is a testament to the company's pioneering spirit, harnessing the power of bioelectronics to offer a non-invasive, drug-free alternative for individuals suffering from these conditions. Available through the company's direct-to-consumer channels, including its website, Amazon.com, Walmart.com, and other U.S. online retailers like BestBuy and FSAStore, ClearUP aims to revolutionize the way individuals manage sinus and nasal congestion, prioritizing efficiency and user-friendliness.